All stock reports

EUROTEXIND evidence report

Evidence date: 2026-10-01. Research observations only.

What can I do with this stock?

Evaluated 2026-10-02T01:37:53.224812+00:00. Closed-session evidence: 2026-10-01. This is a timestamped assessment, not a live trading feed.

Strategy evidence, instrument feasibility and portfolio suitability are separate. Portfolio suitability has not been assessed.

Today: intraday

Evidence unavailable

No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.

  • No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.

Next week: five trading sessions

Evidence unavailable

1 opportunity assessments; compare evidence and conditions below.

Event Gap Reaction

Evidence unavailable. Direction: LONG.

Tests whether a material opening gap is accepted rather than immediately rejected

  • Candidate data quality and liquidity must both pass.
Eligible expression
None selected
Expression comparison
No eligible instrument selected.
Invalidation
Gap fill and reversal below prior close
Entry rule
Not supplied
Entry range (INR)
Not supplied
Exit / review rule
Not supplied
Planned exit
Not supplied
Plan valid until
Not supplied
Promotion reference
Not supplied
Instrument scenarios in INR; quantities are illustrative, not personal sizing
InstrumentEvidence statusContractQuantityCapital / marginTarget P&L after costsStop-level scenario P&LStress lossConditions and limitations

Long term: one to three years

Research only

A financial screen alone does not establish an investment recommendation.

  • A current, source-backed thesis and valuation review is required.

Investment evidence

Statement coverage
FULL_STATEMENTS
Financial source retrieved
2026-09-07T23:40:10.475444+00:00

Metrics

latest_annual_period
2026-03-31
revenue
1083000.0
net_income
-7949000.0
operating_cash_flow
-46947000.0
free_cash_flow
-47444000.0
total_assets
310664000.0
total_liabilities
579993000.0
total_equity
-269329000.0
cash
1553000.0
total_debt
356975000.0
revenue_growth
-0.9063553826199741
earnings_growth
-0.5437639901279918
net_margin
-7.339796860572484
roe
0.02951408871677391
debt_to_equity
-1.3254235526066633
cash_conversion
5.906025915209461
free_cash_flow_margin
-43.80794090489381
trailing_pe
Not supplied
forward_pe
0.0
peg_ratio
Not supplied
price_to_book
1.7596
dividend_yield
Not supplied

Other positional research

Evidence unavailable

1 opportunity assessments; compare evidence and conditions below.

Breakout Volatility Expansion

Evidence unavailable. Direction: LONG.

Tests range escape confirmed by participation expansion

  • Candidate data quality and liquidity must both pass.
Eligible expression
None selected
Expression comparison
No eligible instrument selected.
Invalidation
False breakout back into range
Entry rule
Not supplied
Entry range (INR)
Not supplied
Exit / review rule
Not supplied
Planned exit
Not supplied
Plan valid until
Not supplied
Promotion reference
Not supplied
Instrument scenarios in INR; quantities are illustrative, not personal sizing
InstrumentEvidence statusContractQuantityCapital / marginTarget P&L after costsStop-level scenario P&LStress lossConditions and limitations
Decision provenance and limitations
Decision ID
decision-3508284a1508fb297043f2b563814de6829e99435f85a78c4d14b649100bec6f
Policy
stock-decisions-v1
Evidence bundle hash
9368e00cda7a29a68894eab3d19c8e693141a152a1f4bbb26f4c815af5a4a983
  • market-brief: a7de4d64fedac164d48cdfb9b4081a4666d7f797f7d9c58da304b329b3a61d3c
  • validation-registry: b1069587129bfc64a703cdf8322d0294692585b7d67f5472593e4164bbb0c3bc
  • financial-statements: 489b4684a0d76aa68f76bcda76031079bcd0a111525cd2db1e7b236de3786bd8
  • daily-price: b66f0694bc66f84d772f6f4c6db2e3c99970991104986cfa9bc04eeb9d943df7
  • Conditional research decisions are not orders or personalized position sizes.
  • Scenario payoffs are assumptions, not probabilities or expected returns.
  • A stop price does not guarantee a maximum loss through a gap or illiquidity.

Download the decision evidence as JSON

Evidence briefing

The local language model selected and grouped the following supplied facts.

Overview

Price source verification: REPAIRED. The cached closing price on 2026-10-01 was INR 15.73. The trailing 5-session price return was 28.83%. The trailing 20-session price return was 12.44%. The trailing 60-session price return was 3.15%. The trailing 250-session price return was 2.08%.

Risks

Average cached traded value over twenty sessions was INR 47,789. The closing price was -33.29% below its highest close in the available trailing year. The cached financial metric revenue growth is -0.9063553826199741. The cached financial metric net margin is -7.339796860572484. The cached financial metric roe is 0.02951408871677391. The cached financial metric debt to equity is -1.3254235526066633.

Follow Up

The cached financial metric cash conversion is 5.906025915209461. The cached financial metric free cash flow margin is -43.80794090489381. Historical observations do not establish future returns. No verified current news or catalyst evidence is supplied.

Cached observations and evidence limits